Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel P Judge

Showing results (161-170 of 260) with videos related to

Pageof 26
Sort By:
Circulation. Genomic and Precision Medicine|December 14, 2022
Efficacy and Safety of ARRY-371797 in <i>LMNA</i>-Related Dilated Cardiomyopathy: A Phase 2 StudyCalum A MacRae, Matthew R G Taylor, Luisa Mestroni, et al.
Annals of Neurology|July 22, 2014
Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophyDoris G Leung, Daniel A Herzka, W Reid Thompson, et al.
Circulation. Heart Failure|July 9, 2024
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic <i>LMNA</i>-Related Dilated CardiomyopathyPablo Garcia-Pavia, Jose Fernando Rodriguez Palomares, Gianfranco Sinagra, et al.
Journal of the American Society of Nephrology : JASN|September 28, 2013
A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney diseaseDongyan Liu, Connie J Wang, Daniel P Judge, et al.
JAMA Cardiology|November 16, 2022
Knowledge of Genome Sequencing and Trust in Medical Researchers Among Patients of Different Racial and Ethnic Groups With Idiopathic Dilated CardiomyopathyHanyu Ni, Elizabeth Jordan, Jinwen Cao, et al.
Circulation|March 22, 2006
Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2Darshan Dalal, Lorraine H Molin, Jonathan Piccini, et al.
Journal of the American College of Cardiology|July 2, 2013
Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriersAnneline S J M te Riele, Aditya Bhonsale, Cynthia A James, et al.
European Journal of Heart Failure|May 30, 2026
Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: Findings from ATTRibute-CMMarianna Fontana, Francesco Cappelli, Pablo Garcia-Pavia, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 8, 2017
Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devicesBrian A Houston, Andrea L C Schneider, Joban Vaishnav, et al.
Nature|January 29, 2013
Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCsChangsung Kim, Johnson Wong, Jianyan Wen, et al.
Pageof 26

Showing results (161-170 of 260) with videos related to

Sort By:
Pageof 26
Circulation. Genomic and Precision Medicine|December 14, 2022
Efficacy and Safety of ARRY-371797 in <i>LMNA</i>-Related Dilated Cardiomyopathy: A Phase 2 StudyCalum A MacRae, Matthew R G Taylor, Luisa Mestroni, et al.
Annals of Neurology|July 22, 2014
Sildenafil does not improve cardiomyopathy in Duchenne/Becker muscular dystrophyDoris G Leung, Daniel A Herzka, W Reid Thompson, et al.
Circulation. Heart Failure|July 9, 2024
REALM-DCM: A Phase 3, Multinational, Randomized, Placebo-Controlled Trial of ARRY-371797 in Patients With Symptomatic <i>LMNA</i>-Related Dilated CardiomyopathyPablo Garcia-Pavia, Jose Fernando Rodriguez Palomares, Gianfranco Sinagra, et al.
Journal of the American Society of Nephrology : JASN|September 28, 2013
A Pkd1-Fbn1 genetic interaction implicates TGF-β signaling in the pathogenesis of vascular complications in autosomal dominant polycystic kidney diseaseDongyan Liu, Connie J Wang, Daniel P Judge, et al.
JAMA Cardiology|November 16, 2022
Knowledge of Genome Sequencing and Trust in Medical Researchers Among Patients of Different Racial and Ethnic Groups With Idiopathic Dilated CardiomyopathyHanyu Ni, Elizabeth Jordan, Jinwen Cao, et al.
Circulation|March 22, 2006
Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2Darshan Dalal, Lorraine H Molin, Jonathan Piccini, et al.
Journal of the American College of Cardiology|July 2, 2013
Incremental value of cardiac magnetic resonance imaging in arrhythmic risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy-associated desmosomal mutation carriersAnneline S J M te Riele, Aditya Bhonsale, Cynthia A James, et al.
European Journal of Heart Failure|May 30, 2026
Outpatient worsening heart failure in transthyretin amyloid cardiomyopathy: Findings from ATTRibute-CMMarianna Fontana, Francesco Cappelli, Pablo Garcia-Pavia, et al.
The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 8, 2017
Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devicesBrian A Houston, Andrea L C Schneider, Joban Vaishnav, et al.
Nature|January 29, 2013
Studying arrhythmogenic right ventricular dysplasia with patient-specific iPSCsChangsung Kim, Johnson Wong, Jianyan Wen, et al.
Pageof 26